Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Brazilian (BOVESPA) Healthcare Services Industry Analysis

UpdatedMay 21, 2026
DataAggregated Company Financials
Companies11
  • 7D-0.2%
  • 3M-19.2%
  • 1Y-13.2%
  • YTD-12.1%

In the last week, the Healthcare Services industry is flat overall, with Diagnósticos da América standing out by going down 8.3%. Unfortunately though, the industry is down 13% over the past 12 months. As for the next few years, earnings are expected to grow by 26% per annum.

Industry Valuation and Performance

Has the Brazilian Healthcare Services Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 21 May 2026R$108.3bR$143.1bR$679.8m13.8x159.3x0.8x
Sat, 18 Apr 2026R$122.2bR$142.9bR$1.1b16.2x108x0.9x
Mon, 16 Mar 2026R$111.4bR$143.8bR$1.9b17.2x59.8x0.8x
Wed, 11 Feb 2026R$127.2bR$141.9bR$588.8m17.9x216.1x0.9x
Fri, 09 Jan 2026R$125.9bR$141.9bR$588.8m17x213.8x0.9x
Sun, 07 Dec 2025R$128.4bR$141.9bR$588.8m16.3x218x0.9x
Tue, 04 Nov 2025R$134.1bR$140.3bR$1.4b12.6x97.6x1x
Thu, 02 Oct 2025R$133.8bR$140.1bR$1.4b13.4x97.2x1x
Sat, 30 Aug 2025R$129.5bR$140.1bR$1.4b12.9x94.1x0.9x
Mon, 28 Jul 2025R$111.2bR$139.7bR$877.7m12.6x126.7x0.8x
Wed, 25 Jun 2025R$119.1bR$139.7bR$877.7m11.4x135.7x0.9x
Fri, 23 May 2025R$123.6bR$139.8bR$871.7m10.8x141.8x0.9x
Sun, 20 Apr 2025R$105.2bR$140.2bR$562.7m10.9x186.9x0.8x
Tue, 18 Mar 2025R$103.9bR$137.3bR$3.1b13.9x33.1x0.8x
Thu, 13 Feb 2025R$104.4bR$136.0bR$2.9b11.7x36.3x0.8x
Sat, 11 Jan 2025R$96.1bR$136.0bR$2.9b10.5x33.4x0.7x
Mon, 09 Dec 2024R$101.7bR$136.0bR$2.9b11.6x35.3x0.7x
Wed, 06 Nov 2024R$117.2bR$134.4bR$2.5b12.7x46.5x0.9x
Fri, 04 Oct 2024R$123.3bR$134.1bR$2.5b12.7x49.3x0.9x
Sun, 01 Sep 2024R$130.8bR$134.1bR$2.5b13.2x52.3x1x
Tue, 30 Jul 2024R$120.8bR$132.6bR$2.3b13.5x51.8x0.9x
Thu, 27 Jun 2024R$112.1bR$132.2bR$2.4b12.9x47.7x0.8x
Sat, 25 May 2024R$125.2bR$132.2bR$2.3b15.6x53.5x0.9x
Mon, 22 Apr 2024R$109.5bR$129.5bR$1.4b15.8x78.6x0.8x
Wed, 20 Mar 2024R$120.9bR$122.8bR$806.9m19.4x149.8x1x
Fri, 16 Feb 2024R$119.5bR$122.1bR$729.3m23.1x163.9x1x
Sun, 14 Jan 2024R$140.1bR$124.2bR$902.0m25.4x155.3x1.1x
Tue, 12 Dec 2023R$133.0bR$124.2bR$902.0m26x147.4x1.1x
Thu, 09 Nov 2023R$129.3bR$115.4bR$765.5m23x168.9x1.1x
Sat, 07 Oct 2023R$126.6bR$115.3bR$753.8m24.6x168x1.1x
Mon, 04 Sep 2023R$141.6bR$115.3bR$753.8m26.3x187.8x1.2x
Wed, 02 Aug 2023R$164.0bR$106.3bR$737.3m30.8x222.5x1.5x
Fri, 30 Jun 2023R$148.9bR$106.3bR$737.3m29.8x201.9x1.4x
Sun, 28 May 2023R$134.8bR$100.4bR$671.8m24.8x200.6x1.3x
Price to Earnings Ratio

200.6x


Total Market Cap: R$134.8bTotal Earnings: R$671.8mTotal Revenue: R$100.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Brazilian Healthcare Services Industry Price to Earnings3Y Average 117x202420252026
Current Industry PE
  • Investors are optimistic on the Brazilian Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 159x which is higher than its 3-year average PE of 117x.
  • The industry is trading close to its 3-year average PS ratio of 0.95x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 13% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Brazilian Healthcare industry?

BR Market-0.69%
Healthcare-0.55%
Healthcare Services-0.23%
Healthcare Facilities0.62%
Managed Healthcare-1.96%
Healthcare Services-2.36%
Healthcare Distributors-8.70%
Industry PE
  • Investors are most optimistic about the Managed Healthcare industry which is trading above its 3-year average PE ratio.
    • Analysts are expecting annual earnings growth of 30.7%, which is higher than its past year's earnings growth of 0.5% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 55% over the next 5 years.
  • This is better than its past earnings growth rate of 1.2% per year.
  • In contrast, the Healthcare Distributors industry is expected to see its earnings decline by 35% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
RDOR3 Rede D'Or São LuizR$34.990.7%
+R$527.8m		-3.6%PE16.7x
ONCO3 Oncoclínicas do Brasil Serviços MédicosR$1.256.8%
+R$89.5m		-73.7%PS0.3x
HAPV3 Hapvida Participações e InvestimentosR$13.270.08%
+R$4.7m		-68.8%PS0.2x
QUAL3 Qualicorp Consultoria e Corretora de SegurosR$1.860.5%
+R$2.8m		-14.3%PS0.4x

Latest News

ONCO3
R$1.25
Oncoclínicas do Brasil Serviços Médicos
7D
6.8%
1Y
-73.7%
VVEO3
R$1.16
CM Hospitalar S/A
7D
-14.1%
1Y
-13.4%
HAPV3
R$13.27
Hapvida Participações e Investimentos
7D
0.08%
1Y
-68.8%
Narrative Update • May 19

HAPV3: Contract Repricing Will Reshape Margins And Support Future Upside

Analysts have reset their price target for Hapvida Participações e Investimentos to R$19 from R$26.16, reflecting a higher discount rate, more cautious assumptions on revenue growth and profit margins, and a higher future P/E multiple as they factor in both recent operational issues and expected benefits from contract repricing. Analyst Commentary Recent Street research shows a split view on Hapvida Participações e Investimentos, with some firms turning more cautious while others highlight potential upside as contract repricing and internal adjustments progress.
FLRY3
R$15.80
Fleury
7D
-1.0%
1Y
26.7%
Analysis Article • May 18

Fleury (BVMF:FLRY3) Is Posting Promising Earnings But The Good News Doesn’t Stop There

The market seemed underwhelmed by last week's earnings announcement from Fleury S.A. ( BVMF:FLRY3 ) despite the healthy...
DASA3
R$3.10
Diagnósticos da América
7D
-8.3%
1Y
78.2%
RDOR3
R$34.99
Rede D'Or São Luiz
7D
0.7%
1Y
-3.6%
Narrative Update • May 15

RDOR3: Equity Interest Payout Will Support Repricing Despite Index Removal

Analysts now see fair value for Rede D'Or São Luiz at about R$49.71 per share, compared with the previous R$51.46. The revision reflects updated assumptions around discount rate, revenue growth, profit margin and future P/E.
SAUD3
R$13.35
Bradsaúde
7D
-3.8%
1Y
22.3%
Narrative Update • May 13

SAUD3: Share Merger Steps And Refined Assumptions Will Shape Balanced Outlook

Analysts now see Bradsaúde’s fair value moving from R$14.90 to about R$15.12, citing updated assumptions around discount rates, revenue growth, profit margins and future P/E that slightly adjust the stock’s risk and earnings outlook. What's in the News Bradsaúde is linked to a Board Meeting at Odontoprev S.A. scheduled for May 4, 2026, at 12:00 Coordinated Universal Time to consider approval of Odontoprev's first quarter 2026 results (Key Developments).
PFRM3
R$6.35
Profarma Distribuidora de Produtos Farmacêuticos
7D
-5.9%
1Y
-25.6%
MATD3
R$5.26
Hospital Mater Dei
7D
-2.2%
1Y
9.1%
QUAL3
R$1.86
Qualicorp Consultoria e Corretora de Seguros
7D
0.5%
1Y
-14.3%